Objective To analyze whether infants admitted to hospital with Acute Viral Bronchiolitis
(AVB), who received glucocorticoids and bronchodilators, and who had an atopic …

Acute Viral Bronchiolitis is one of the leading causes of hospitalization in the first 12–24
months of life. International guidelines on the management of bronchiolitis broadly agree in …

Purpose We investigated the influence of respiratory virus and atopic characteristics on the
severity of bronchiolitis. Methods Four hundred and eighteen infants< 2-years-old and …

Background: Our aim was to evaluate the association between viral findings during
bronchiolitis and the use of asthma controller medication (primary outcome) and systemic …

Introduction Despite advances in medical knowledge, the treatment of viral bronchiolitis is
mainly supportive. Antiviral therapies are being investigated in clinical trials. Identifying …

Rationale: Bronchiolitis is a common cause of lower respiratory tract infection. The diagnosis
is clinical, but it is still controversial the definition and the upper limit age. In North America …

Viral respiratory infections are often grouped as a single respiratory syndrome named 'viral
bronchiolitis', independently of the viral etiology or individual risk factors. Clinical trials and …

BACKGROUND AND OBJECTIVE Bronchiolitis is the leading cause of hospitalization for US
infants and is associated with increased risk of childhood asthma. Although studies have …

BACKGROUND AND OBJECTIVE: Meta-analyses show that corticosteroids are not effective
in patients with bronchiolitis. However, risk factors for asthma such as eczema or familial …

Introduction and objectives Despite the recommendation against routine use of inhaled
bronchodilators in infants with viral bronchiolitis given in the main clinical practice guidelines …